- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03682913
Personalized Inhibitory Control Training for Compulsive Behavior Change
25. september 2018 opdateret af: Shahaf Leshem, Hebrew University of Jerusalem
Obsessive-compulsive disorder (OCD) is a severe mental illness characterized by repetitive behaviors that a person feels compelled to perform.
It has been demonstrated that stimuli in the environment can trigger the compulsive urge, perpetuating the OCD cycle.
The main goal of the current proposal, which is based on exciting pilot data, is to test a novel computerized training program to create an association between OCD-related stimuli, which typically trigger the compulsive urge, and the brain system responsible for stopping.
The idea is that once this system is triggered, it will be easier for patients to stop the compulsive urge.
Studieoversigt
Status
Ukendt
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Forventet)
50
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Shahaf Leshem, B.A.
- Telefonnummer: 0545455509
- E-mail: shahaf.leshem@mail.huji.ac.il
Studiesteder
-
-
-
Jerusalem, Israel
- Rekruttering
- The Hebrew University of Jerusalem
-
Kontakt:
- Shahaf Leshem
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ja
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- OCD patients
Exclusion Criteria:
- Metal/ electronic device
- Under the age of 18
- Pregnant women
- Tattoos that cover over 10% of body mass
- Chronically ill patients
- Psychosis/ Bi-polar
- Substance abuse
- Sever depression
- Active suicide thoughts
- Hearing loss
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Firedobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: P-CIT protocol
OCD patients who receive the P-CIT intervention.
|
Personalized inhibitory control training for one week.
|
Placebo komparator: Placebo
OCD patients who don't receive the P-CIT intervention.
|
without personalized inhibitory control training for one week.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
fMRI- changed inhibition levels in the pre-SMA area in experimental group in comparison to control group
Tidsramme: One week after P-CIT training starts
|
During tasks that require inhibition
|
One week after P-CIT training starts
|
fMRI- changed inhibition levels in the rIFG area in experimental group in comparison to control group
Tidsramme: One week after P-CIT training starts
|
During tasks that require inhibition
|
One week after P-CIT training starts
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Behavioural- Y-bocs (Yale-Brown Obsessive-Compulsive Scale) score- change in OCD symptoms in experimental group in comparison to placebo group
Tidsramme: One week after P-CIT (Personalized Inhibitory Control Training for Compulsive Behavior Change) training
|
Clinical assessment.
Semi-structured interview that assesses the presence and severity of obsessions and compulsions over the past week.
The 5-item Obsession Severity and Compulsion Severity subscales are summed to produce a Total Severity score.
Symptoms endorsed are rated on a scale from none (0) to extreme (5).
The 5-item Obsession Severity and Compulsion Severity subscales are summed to produce a Total Severity score.
|
One week after P-CIT (Personalized Inhibitory Control Training for Compulsive Behavior Change) training
|
Behavioural- M.I.N.I (Mini-International Neuropsychiatric Interview) score- change in OCD symptoms in experimental group in comparison to placebo group
Tidsramme: One week after P-CIT (Personalized Inhibitory Control Training for Compulsive Behavior Change) training
|
Clinical assessment.
Structural interview.
|
One week after P-CIT (Personalized Inhibitory Control Training for Compulsive Behavior Change) training
|
Behavioural- OCI-R (Obsessive-Compulsive Inventory) score- change in OCD symptoms in experimental group in comparison to placebo group
Tidsramme: One week after P-CIT (Personalized Inhibitory Control Training for Compulsive Behavior Change) training
|
Clinical assessment.
Cutoff score of 21 is distinguish individuals with OCD from those without anxiety disorders.
|
One week after P-CIT (Personalized Inhibitory Control Training for Compulsive Behavior Change) training
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
1. juli 2018
Primær færdiggørelse (Forventet)
30. juli 2019
Studieafslutning (Forventet)
30. august 2019
Datoer for studieregistrering
Først indsendt
23. august 2018
Først indsendt, der opfyldte QC-kriterier
20. september 2018
Først opslået (Faktiske)
25. september 2018
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
27. september 2018
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
25. september 2018
Sidst verificeret
1. september 2018
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 0105-18-HMO
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med OCD
-
University of PennsylvaniaNational Institute of Mental Health (NIMH); New York University; New York... og andre samarbejdspartnereRekruttering
-
University of MinnesotaU.S. National Science FoundationAfsluttet
-
Boston University Charles River CampusIkke rekrutterer endnu
-
Stanford UniversityAfsluttet
-
University of Sao PauloAfsluttet
-
University of FloridaInternational OCD FoundationRekruttering
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...Ukendt
-
University of MinnesotaNational Institute of Mental Health (NIMH)Afsluttet
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...Rekruttering
Kliniske forsøg med P-CIT protocol
-
Chang Gung Memorial HospitalNational Science Council, Taiwan; National Health Research Institutes,...AfsluttetCerebrovaskulære ulykkerTaiwan
-
Columbia UniversityNational Institute of Mental Health (NIMH); Wayne State University; University... og andre samarbejdspartnereTilmelding efter invitationBetjentenes færdigheder og adfærdForenede Stater
-
National Taiwan University HospitalRekruttering
-
Asklepion Pharmaceuticals, LLCRekrutteringAkut Vaso-okklusiv krise (VOC)Forenede Stater
-
Institute for Neurodegenerative DisordersUnited States Department of Defense; Molecular NeuroImagingAktiv, ikke rekrutterendeParkinsons sygdomForenede Stater
-
St Mary's Hospital for ChildrenUkendtCerebral Parese | Hemiplegi | Svaghed i den øvre ekstremitetForenede Stater
-
Asklepion Pharmaceuticals, LLCAfsluttetAkut hypoxæmisk respirationssvigtForenede Stater
-
Institute for Neurodegenerative DisordersUnited States Department of Defense; Molecular NeuroImagingAfsluttetParkinsons sygdom | Parkinsons syndromForenede Stater
-
Fresenius Medical Care Deutschland GmbHAfsluttetHjerte-kar-sygdomme | Nyresvigt | Vaskulær forkalkningSpanien
-
Institute for Neurodegenerative DisordersUnited States Department of Defense; Molecular NeuroImagingAfsluttetParkinsons sygdom | Parkinsons syndromForenede Stater